Hiv Vaccine Trials Network

This early-stage trial tested an experimental HIV vaccine in 38 healthy infants born to HIV-positive mothers. The vaccine was designed to teach the immune system to recognize HIV. The main goal was to see if it was safe and whether it triggered an immune response. The study is co…

This early-stage trial tested two experimental HIV vaccines in 34 healthy, HIV-negative adults. The goal was to see if the vaccines were safe and whether they triggered an immune response. The vaccines use a harmless chimpanzee virus to deliver HIV proteins, followed by a booster…

This study looked at whether an experimental antibody called VRC01 could help people with HIV control the virus after they stop taking their daily HIV medication. Thirteen people who had received VRC01 or a placebo in an earlier study and later got HIV took part. They paused thei…

This completed study enrolled 760 adults who had tested positive for SARS-CoV-2 and recovered. Researchers collected blood and nasal samples to measure antibodies and immune cells. The goal was to understand how the body's immune system responds to natural infection, which could …